Thermo Fisher reported strong earnings and a $4 billion share buyback plan, but insiders sold shares recently.

Thermo Fisher Scientific Inc. saw mixed institutional investment activity, with some firms increasing and others decreasing their stakes. The company reported strong earnings, beating estimates by $0.03 to $5.28 per share, and has a $4 billion share repurchase plan approved. CEO Marc N. Casper and other insiders have sold shares recently. Thermo Fisher has a "Moderate Buy" rating with an average price target of $650.05.

3 months ago
7 Articles